Rhumbline Advisers Cuts Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 83,325 shares of the medical research company’s stock after selling 3,009 shares […]
Rhumbline Advisers cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 83,325 shares of the medical research company’s stock after selling 3,009 shares […]
